Dallas, TX -- (SBWIRE) -- 10/01/2018 --

The global Life Science analytics market is expected to register a CAGR of nearly 12.5 % during the forecast period, 2018-2023. The application of analytics has emerged as a useful tool for numerous pharmaceutical, medical device and biotechnological enterprises, as these choices help to overcome challenges in data integration and enhance operational efficiency. The key applications of analytics in pharmaceutical and life sciences include regulatory compliance reporting, marketing and product or service enablement.

Companies Mentioned:
Oracle Corporation, Quintiles, Inc., SAS Institute Inc., Ibm Corporation, Maxisit, Scio Health Analytics, Take Solutions, Wipro Limited, Accenture, Cognizant, among others.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/2326564?utm_source=km

Increasing Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials

There is a rise in use of analytics in clinical trials as the clinical trials conduction has become a complex process where it involves many activities and generates high volumes of data from different systems. With changing regulatory protocol requirements for clinical trial conduction and challenge in data collection, analyzing and report preparation for quick submission to health authority, hence the use of analytics in clinical trials is rising.

Analytics will help in optimizing the drug discovery and improve the efficiency of clinical trials. With huge data generated from Research & Development process and clinical research, the pharma companies can identify potential drug candidates with high probability of successfully developing in to drugs. Most contract research organizations (CROs) with established systems for Data capture, advanced analytics are now incorporated across all systems such as drug discovery, clinical development and CRO's which is providing real time analysis and creating alerts to each divisions concerning safety or efficacy. Application of analytics in evaluating a potential drug candidate for clinical development may reduce the time and R&D expenditure. Eli Lilly's has developed Phenotypic Drug Discovery Platform, where researchers can screen their compounds without giving intellectual property. The importance of Real-time analysis has become more important to pharmaceutical companies as payers impose value-based pricing, health authorities offering incentives for health outcomes. Some companies are in creating networks to collect, analyze, share and respond to queries on health outcomes.

Other factors that drive this market include advancements in technology, and growing pressure to reduce healthcare spending.

High Implementation Costs

Life science companies that include Pharma, contract research organization (CRO) and others face increasing pressure to allocate budget in establishing infrastructure for analytics division. Many companies in the past never had a clear understanding about the role of analytics in Pharma or clinical trials. Those companies that recognized the importance of analytics have established their own in house analytics department or outsourced to third party their requirement.

Costs increase sometimes if a company they have bought a subscription based analytical tool for their business and after a period of time realize that the selected analytical tool doesn't meet their business needs. All the costs associated with installation and implementation processes are lost investment for the company. Major companies like Pfizer with deep pockets to invest already have their own Real World Data and Analytics centers and applying those analytics-generated insights to deliver personalized care services. Mid-size and small companies pose high cost for partnering with established analytics companies to explore their strategy for business development opportunities. Hence, high implementation costs are restraining the growth of life science analytics market.

Other factor impeding this market include lack of skilled personnel.

Browse the complete report @ http://www.orbisresearch.com/reports/index/global-life-science-analytics-market-growth-trends-and-forecast-2018-2023?utm_source=km

US dominates the North American Region For Life Science Analytics Market

The US accounts for the largest share in the North America region for the market studied. This can be primarily attributed to presence of more number of pharmaceutical companies and even more number of clinical trials are occurring in this region, which are expected to augment the growth of the market studied over the forecast period.

Key Developments in the Life Science Analytics Market

May 2018: Sanofi Chooses Accenture Interactive to Create UWell's Healthcare Platform to Better Serve Consumers.

Major Players:

ORACLE CORPORATION, QUINTILES, INC., SAS INSTITUTE INC., IBM CORPORATION, MAXISIT, SCIO HEALTH ANALYTICS, TAKE SOLUTIONS, WIPRO LIMITED, ACCENTURE, COGNIZANT, among others.

Reasons to Purchase Life Science Analytics Market Report

Current and future of Life Science analytics market outlook in the developed and emerging markets
Analysis of various perspectives of the market with the help of Porter's five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of Life Science Analytics Market Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

Make an enquiry of this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2326564?utm_source=km

About Orbis Research
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas - 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +912064101019